Profil
Rosemary Harrison is currently the Chief Business & Strategy Officer at TCR2 Therapeutics, Inc. She previously worked as the Senior VP-Corporate Development & Strategy at Trillium Therapeutics ULC from 2020 to 2021, Head-Portfolio Management & Strategic Planning at Novartis Institutes for Biomedical Research, Inc. from 2015 to 2018, and Head-Rare Diseases at Imbria Pharmaceuticals, Inc. from 2019 to 2020.
She holds a doctorate degree from The University of Queensland.
Postes actifs de Rosemary Harrison
| Sociétés | Poste | Début |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01/01/2022 |
Anciens postes connus de Rosemary Harrison
| Sociétés | Poste | Fin |
|---|---|---|
| TRILLIUM THERAPEUTICS | Investor Relations Contact | 01/11/2021 |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Corporate Officer/Principal | 01/03/2020 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/05/2018 |
Formation de Rosemary Harrison
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
















